Style | Citing Format |
---|---|
MLA | Bahmani M, et al.. "Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natural Substitutes." Current Pharmaceutical Design, vol. 23, no. 6, 2017, pp. 952-960. |
APA | Bahmani M, Sarrafchi A, Shirzad H, Asgari S, Rafieiankopaei M (2017). Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natural Substitutes. Current Pharmaceutical Design, 23(6), 952-960. |
Chicago | Bahmani M, Sarrafchi A, Shirzad H, Asgari S, Rafieiankopaei M. "Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natural Substitutes." Current Pharmaceutical Design 23, no. 6 (2017): 952-960. |
Harvard | Bahmani M et al. (2017) 'Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natural Substitutes', Current Pharmaceutical Design, 23(6), pp. 952-960. |
Vancouver | Bahmani M, Sarrafchi A, Shirzad H, Asgari S, Rafieiankopaei M. Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natural Substitutes. Current Pharmaceutical Design. 2017;23(6):952-960. |
BibTex | @article{ author = {Bahmani M and Sarrafchi A and Shirzad H and Asgari S and Rafieiankopaei M}, title = {Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natural Substitutes}, journal = {Current Pharmaceutical Design}, volume = {23}, number = {6}, pages = {952-960}, year = {2017} } |
RIS | TY - JOUR AU - Bahmani M AU - Sarrafchi A AU - Shirzad H AU - Asgari S AU - Rafieiankopaei M TI - Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natural Substitutes JO - Current Pharmaceutical Design VL - 23 IS - 6 SP - 952 EP - 960 PY - 2017 ER - |